|

Cevostamab Clinical Trials

4 actively recruiting trials across 1 location

Also known as: BFCR4350A, RO7187797

Pipeline

Phase 1: 3Phase 1/2: 1

Top Sponsors

  • Hoffmann-La Roche2
  • Regeneron Pharmaceuticals1
  • Genentech, Inc.1

Indications

  • Cancer4
  • Multiple Myeloma3
  • Relapsed or Refractory Multiple Myeloma1

Other3 trials

A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
Phase 1
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Phase 1/2
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Phase 1

La Jolla, California1 trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Scripps Clinic Torrey Pines

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.